Based on the forecasted data, the sales of antidepressant medications in Germany are expected to decline from 2024 to 2028. The total sales value is projected to decrease gradually from 1.3 in 2024 to 1.0 by 2028. This indicates an average compound annual growth rate (CAGR) that reflects a decreasing trend in antidepressant sales over this period. In 2023, sales had already shown signs of reaching a plateau, suggesting market saturation or shifts in healthcare practices.

For future trends, watch for:

Potential changes in healthcare policies affecting prescription practices.
Development and acceptance of alternative treatments like psychotherapy or newer pharmacological agents.
Influence of socioeconomic factors and public mental health awareness on antidepressant demand.
Impact of generic medications on the market dynamics and overall sales value.